Eli Lilly | LLY - Market Capitalization


Eli Lilly reported $1.08T in Market Capitalization this June of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 384.69B 19.14B Mar/2026
Abbott USD 178.41B 39.46B Mar/2026
ALKERMES USD 5.88B 1.26B Mar/2026
Amgen USD 189.89B 13.64B Mar/2026
AstraZeneca USD 301.25B 13.1B Mar/2026
Baxter International USD 8.67B 1.15B Mar/2026
Biogen USD 26.9B 1.09B Mar/2026
Bristol-Myers Squibb USD 123.83B 14.02B Mar/2026
Coherus Biosciences USD 172M 19M Dec/2025
Eli Lilly USD 869.02B 146.97B Mar/2026
Gilead Sciences USD 172.99B 20.71B Mar/2026
GlaxoSmithKline GBP 83.8B 9.44B Mar/2026
J&J USD 579.15B 78.91B Mar/2026
Medtronic USD 94.38B 12.6B Jun/2026
Merck USD 297.1B 35.84B Mar/2026
Neurocrine Biosciences USD 13.25B 890M Mar/2026
Novartis USD 307.76B 15.54B Mar/2026
Novo Nordisk A/S DKK 1.03T 421.31B Mar/2026
Perrigo USD 1.31B 604M Mar/2026
Pfizer USD 153.81B 12.24B Mar/2026
Phibro Animal Health USD 1.51B 126M Dec/2025
Prestige Brands USD 2.8B 161M Mar/2026
Regeneron Pharmaceuticals USD 81.68B 560M Mar/2026
Roche Holding CHF 266.34B 55.46B Dec/2025
Sanofi EUR 100.27B 605.48M Mar/2026
United Therapeutics USD 25.19B 4.21B Mar/2026
Zoetis USD 49.71B 5.74B Mar/2026